健康AI评估基准缺乏真实患者数据，导致模型能力被高估。

Background: Clinical trials rely on transparent inclusion criteria to ensure generalizability. In contrast, benchmarks validating health-related large language models (LLMs) rarely characterize the "patient" or "query" populations they contain. Without defined composition, aggregate performance metrics may misrepresent model readiness for clinical use. Methods: We analyzed 18,707 consumer health queries across six public benchmarks using LLMs as automated coding instruments to apply a standardized 16-field taxonomy profiling context, topic, and intent. Results: We identified a structural "validity gap." While benchmarks have evolved from static retrieval to interactive dialogue, clinical composition remains misaligned with real-world needs. Although 42% of the corpus referenced objective data, this was polarized toward wellness-focused wearable signals (17.7%); complex diagnostic inputs remained rare, including laboratory values (5.2%), imaging (3.8%), and raw medical records (0.6%). Safety-critical scenarios were effectively absent: suicide/self-harm queries comprised <0.7% of the corpus and chronic disease management only 5.5%. Benchmarks also neglected vulnerable populations (pediatrics/older adults <11%) and global health needs. Conclusions: Evaluation benchmarks remain misaligned with real-world clinical needs, lacking raw clinical artifacts, adequate representation of vulnerable populations, and longitudinal chronic care scenarios. The field must adopt standardized query profiling--analogous to clinical trial reporting--to align evaluation with the full complexity of clinical practice.